Fascin in Gynecological Cancers: An Update of the Literature
Author | Gupta, Ishita |
Author | Vranic, Semir |
Author | Al-Thawadi, Hamda |
Author | Al Moustafa, Ala-Eddin |
Available date | 2021-11-29T11:14:24Z |
Publication Date | 2021-11-17 |
Publication Name | Cancers |
Identifier | http://dx.doi.org/10.3390/cancers13225760 |
Citation | Gupta, I.; Vranic, S.; Al-Thawadi, H.; Al Moustafa, A.-E. Fascin in Gynecological Cancers: An Update of the Literature. Cancers 2021, 13, 5760. https://doi.org/10.3390/cancers13225760 |
Identifier | 5760 |
Abstract | Fascin is an actin-binding protein that is encoded by the gene (located on chromosome 7). It triggers membrane projections and stimulates cell motility in cancer cells. Fascin overexpression has been described in different types of human cancers in which its expression correlated with tumor growth, migration, invasion, and metastasis. Moreover, overexpression of fascin was found in oncovirus-infected cells, such as human papillomaviruses (HPVs) and Epstein-Barr virus (EBV), disrupting the cell-cell adhesion and enhancing cancer progression. Based on these findings, several studies reported fascin as a potential biomarker and a therapeutic target in various cancers. This review provides a brief overview of the FSCN1 role in various cancers with emphasis on gynecological malignancies. We also discuss fascin interactions with other genes and oncoviruses through which it might induce cancer development and progression. |
Language | en |
Publisher | MDPI |
Subject | biomarker cervical cancer fascin gynecological cancer ovarian cancer |
Type | Article |
Issue Number | 22 |
Volume Number | 13 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [738 items ]
-
Medicine Research [1514 items ]